Biogen
BIIB
#860
Rank
NZ$39.24 B
Marketcap
$269.31
Share price
1.29%
Change (1 day)
-29.31%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$48.25 Billion

According to Biogen's latest financial reports the company's total assets are NZ$48.25 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Biogen - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$42.44 B9.76%
2022-12-31NZ$38.67 B10.63%
2021-12-31NZ$34.95 B2.45%
2020-12-31NZ$34.11 B-15.62%
2019-12-31NZ$40.43 B7.26%
2018-12-31NZ$37.70 B13.2%
2017-12-31NZ$33.30 B0.84%
2016-12-31NZ$33.02 B15.89%
2015-12-31NZ$28.49 B55.99%
2014-12-31NZ$18.26 B26.55%
2013-12-31NZ$14.43 B17.23%
2012-12-31NZ$12.31 B6.2%
2011-12-31NZ$11.59 B10.54%
2010-12-31NZ$10.48 B-10.91%
2009-12-31NZ$11.77 B-19.42%
2008-12-31NZ$14.61 B29.7%
2007-12-31NZ$11.26 B-7.21%
2006-12-31NZ$12.14 B-1%
2005-12-31NZ$12.26 B-4.53%
2004-12-31NZ$12.84 B-12.14%
2003-12-31NZ$14.62 B271.49%
2002-12-31NZ$3.93 B-5.04%
2001-12-31NZ$4.14 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$154.90 B 220.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$91.32 B 89.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$244.44 B 406.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$374.07 B 675.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$303.87 B 529.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.13 B-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$237.07 B 391.27%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$18.07 B-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$10.25 B-78.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$9.51 B-80.28%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands